Alexandra Lazăr, Anca Meda Georgescu, Alexander Vitin and Leonard Azamfirei
[ 4 ], renal cancer [ 5 ], gastrointestinal disorders [ 6 ] orthopaedics [ 7 ], and postoperative care [ 8 ] have been employed these areas.
Pharmacogenomic biomarkers are currently accepted as key components in drug labelling.
Table 1 . list the drugs and also the biomarkers which are related to those drugs.
Table of Pharmacogenomic Biomarkers in Drug Labeling (10)
IFNL3 (IL28B)- genetic variant near the gene encoding interferon-lambda-3